- Home
- LAES vs AMRN Comparison
LAES vs AMRN Comparison
Compare LAES & AMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LAES | AMRN |
|---|---|---|
| Founded | 2022 | 1989 |
| Country | Switzerland | Ireland |
| Employees | N/A | N/A |
| Industry | Semiconductors | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 366.0M | 339.8M |
| IPO Year | N/A | 1993 |
Fundamental Metrics
Financial Performance| Metric | LAES | AMRN |
|---|---|---|
| Price | $5.21 | $16.50 |
| Analyst Decision | Strong Buy | Strong Sell |
| Analyst Count | 2 | 1 |
| Target Price | $6.50 | ★ $12.00 |
| AVG Volume (30 Days) | ★ 10.0M | 102.4K |
| Earning Date | 02-26-2026 | 03-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $10,978,000.00 | ★ $226,733,000.00 |
| Revenue This Year | $66.73 | N/A |
| Revenue Next Year | $92.76 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.99 | $7.08 |
| 52 Week High | $8.71 | $20.90 |
Technical Indicators
Market Signals| Indicator | LAES | AMRN |
|---|---|---|
| Relative Strength Index (RSI) | 65.17 | 63.61 |
| Support Level | $4.17 | $14.50 |
| Resistance Level | $4.93 | $16.80 |
| Average True Range (ATR) | 0.39 | 0.88 |
| MACD | 0.11 | 0.22 |
| Stochastic Oscillator | 79.92 | 92.80 |
Price Performance
Historical ComparisonAbout LAES SEALSQ Corp
SEALSQ Corp develops certified secure microcontrollers and implements post-quantum cryptography. The company develops solutions including post-quantum microchips and devices that can be used in a variety of applications, from multi-factor authentication, home automation, and IT network infrastructure to automotive, industrial automation, and control systems. The company's vaultIC range offers a set of ready-to-use secure elements designed to implement embedded security for any kind of device with fast time-to-market and high flexibility. The company's products include VaultIC155, VaultIV18x, VaultIC292, and VaultIC40x. The company generates a majority of its revenue from North America.
About AMRN Amarin Corporation plc
Amarin Corp PLC is a biopharmaceutical company. It is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa.